Nanosonics (NAN) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of traditional landowners and confirmation of quorum, with over 221 million shares represented by proxies (72.79% of issued shares).

• Board, Company Secretary, and auditors introduced; meeting structure and Q&A/voting procedures explained for both in-person and online attendees.

• AGM opened with a focus on infection prevention and the company's mission to improve patient, clinic, staff, and environmental safety through innovative technologies.

Financial performance review

• FY2025 revenue reached AUD 198.6 million, up 17%, with capital revenue at AUD 52.5 million and recurring revenue at AUD 146.1 million, up 20%.

• Profitability increased 72% to AUD 22.3 million; core trophon business profit rose 31% to AUD 52.8 million.

• Cash flow was strong at AUD 32 million, with a cash balance of AUD 161.6 million and no debt at year-end.

Board and executive committee updates

• Gerard Dalbosco joined as Non-Executive Director and Chair of the Audit and Risk Committee in January.

• Lisa McIntyre stepped down after nearly six years of service.

• Steve Sargent and Gerard Dalbosco re-elected to the Board with strong shareholder support.